LLY's Market Cap Increases by $51B Find Top Trading Robots
As a financial analytics and trader, I am pleased to share some exciting news about Eli Lilly & Co (LLY). The pharmaceutical giant has seen a significant increase in market capitalization, with a $51.0B surge this week. While several factors may contribute to this growth, one notable contributor is the performance of the best trading robots in the market.
Trading robots, also known as algorithmic trading systems, use computer programs to execute trades based on predetermined rules and conditions automatically. These systems are designed to identify and capitalize on market trends and patterns that human traders may miss, allowing for more efficient and effective trading.
In the case of LLY, it is likely that trading robots played a key role in the company's market cap increase. By analyzing market data and executing trades based on predetermined strategies, these systems were able to identify favorable market conditions for LLY and generate gains for investors.
It is worth noting that while trading robots can be powerful tools for traders, they are not infallible. These systems rely on data and algorithms that are only as accurate as the inputs they receive, and unforeseen events or changes in market conditions can still impact their performance.
However, with proper management and oversight, trading robots can provide a valuable advantage for investors and traders looking to maximize their returns. As we continue to see advancements in artificial intelligence and machine learning, it is likely that these systems will become even more sophisticated and effective in the years to come.
LLY's RSI Indicator climbs out of oversold territory
The RSI Oscillator for LLY moved out of oversold territory on November 20, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 29, 2024. You may want to consider a long position or call options on LLY as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LLY just turned positive on November 26, 2024. Looking at past instances where LLY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 358 cases, the price rose further within the following month. The odds of a continued upward trend are .
LLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where LLY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LLY entered a downward trend on November 27, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (67.114) is very high in comparison to the industry average of (5.632). P/E Ratio (131.129) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.440) is also within normal values, averaging (3.004). Dividend Yield (0.006) settles around the average of (0.164) among similar stocks. LLY's P/S Ratio (20.121) is very high in comparison to the industry average of (3.643).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a manufacturer of pharmaceutical products
Industry PharmaceuticalsMajor